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Background Case–control studies have reported the preventive
effect of vitamin or antioxidant intake on cervical neoplasms such
as cervical intraepithelial neoplasia (CIN) and invasive cervical
cancer. However, the findings are inconsistent.
Objective To investigate quantitative effects of vitamin
or antioxidant intake on cervical neoplasm using
meta-analysis.
Search strategy We searched PubMed, EMBASE and the
Cochrane Library in November 2008. All articles searched were
independently reviewed and selected by two evaluators according
to predetermined selection criteria.
Selection criteria We included case–control studies reporting an
association between vitamin or antioxidant intake (or serum
level) and cervical neoplasm risk and reporting the adjusted
odds ratios (OR) and 95% confidence intervals (CI), whenever
possible.
Data collection and analysis After retrieval of data from selected
articles, we performed a meta-analysis using both fixed-effects and
random- effects models.
Main results Of 274 articles meeting our initial criteria, we
included 22 case–control studies involving a total of 10 073
participants. In meta-analyses by type of vitamin or antioxidant, a
significant preventive effect on cervical neoplasm was found in
intakes of vitamin B12 (OR 0.35, 95% CI 0.19–0.63; n = 2),
vitamin C (OR 0.67, 95% CI 0.55–0.82; n = 8), vitamin E (OR
0.56, 95% CI 0.35–0.88; n = 10), and beta-carotene (OR 0.68,
95% CI 0.55–0.84; n = 9).
Authors’ conclusions The findings of this meta-analysis indicate
that overall, there were preventive effects of vitamin or
antioxidant intake on cervical neoplasms in case–control studies.
Keywords Antioxidants, case–control studies, cervical neoplasm,
meta-analysis, vitamins.
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Introduction
Cervical cancer is one of the most important preventable
cancers, as the second most common cancer in women
worldwide, especially in developing countries, although its
incidence and mortality rates have declined in developed
countries, specifically in the USA.1,2
Besides human papillomavirus (HPV) infection, well-
known as the most important risk factor for the develop-
ment of cervical neoplasms such as cervical cancer or cervi-
cal intraepithelial neoplasia (CIN), epidemiological studies
have reported other risk factors such as low socio-eco-
nomic status, smoking, multiple sexual partners, and use of
oral contraceptives.3–6 The relationships between vitamin
or antioxidant micronutrients and cervical neoplasms have
been studied in case–control studies,7–25 but neither cohort
studies nor randomised controlled trials (RCTs) have been
published.
However, the preventive effects of vitamin or antioxidant
intake on cervical neoplasms have not been established and
are controversial in the case–control studies, although
potential biological mechanisms or hypotheses regarding
these micronutrients’ anti-cancer activities and antioxi-
dant effects have been suggested by in vitro or in vivo
studies.26–29
The purpose of this study was to examine the preventive
effects of major vitamins or antioxidants such as carote-
noids, vitamin A, vitamin C, vitamin E, folate, selenium
and lycopene on cervical neoplasm using a meta-analysis of
case–control studies.





Data sources and keywords
We searched MEDLINE (PubMed), EMBASE, and the
Cochrane Library in November 2008 using selected com-
mon keywords regarding vitamin or antioxidant intake (or
serum level) and cervical neoplasm (cervical dysplasia, car-
cinoma in situ [CIS], and cervical cancer) in case–control
studies. We also scanned the bibliographies of relevant arti-
cles to identify additional studies. As the keywords for the
literature search, we selected ‘vitamin’, ‘antioxidant’, ‘reti-
nol (vitamin A)’, ‘beta-carotene’, ‘carotenoids’, ‘ascorbic
acid (vitamin C)’, ‘alpha-tocopherol (vitamin E)’, ‘folate’,
‘selenium’ and ‘lycopene’ for the exposure factors; ‘cervical
cancer’, ‘cervical neoplasm’ and ‘cervical intraepithelial
neoplasia’, for the outcome factors; and ‘case–control stud-
ies’ for the study design.
Study selection
We included case–control studies reporting an association
between vitamin or antioxidant intake (or serum level) and
cervical neoplasm risk and reporting the adjusted odds
ratios (ORs) and 95% CIs, whenever possible. We only
selected articles written in English and excluded those stud-
ies with insufficient data or those reporting disease not
confirmed by biopsy. When the study samples overlapped
in two or more articles, we selected the article with the
most comprehensive population.
All studies retrieved from databases and bibliographies
were independently evaluated by two authors of this study
(SKM and WJ). When there were disagreements between
evaluators concerning the selected studies, they discussed
the matter and reached consensus. Of the articles found in
the three databases, duplicate articles and those that did
not meet the selection criteria were excluded. We extracted
the following data from the studies included in the final
analyses: study name (first author, year of publication),
journal name, country, years enrolled, participants’ charac-
teristics and range of participants’ age, exposure, OR with
95% CI, and adjustments.
Statistical analyses
We used an adjusted OR with 95% CI of the highest intake
(or serum level) group for the disease outcome variable
compared with the lowest intake (or serum level) group
reported in each study, whenever possible. The main analy-
sis was to investigate the association between individual
vitamin or antioxidant intake (or serum level) and risk of
cervical neoplasm. We also conducted subgroup analyses
by type of cervical neoplasm, i.e. CIS and invasive cervical
cancer.
A summary OR with 95% CI was estimated by using
both fixed-effects and random-effects models. For assessing
heterogeneity, we used the Higgins I2, which is calculated
as follows:
I2 ¼ 100% ðQ dfÞ=Q;
where Q is Cochran’s heterogeneity statistic and df is
degrees of freedom.
Negative values of I2 are considered as zero. Values of I2
range from 0% (no heterogeneity) to 100% (maximal het-
erogeneity).30 We considered an I2 > 50% as having sub-
stantial heterogeneity.
Woolfe’s method (inverse variance method) was used in
a fixed-effects model and the DerSimonian and Laird31
method was used in a random-effects model. We used
Stata SE version 10.0 software package (StataCorp,
College Station, TX, USA) for statistical analysis.
Results
Selected studies
Our study included a total of 22 case–control studies (15
hospital-based, four population-based, and three nested
case–control studies), involving a total of 10 073 partici-
pants (3728 cervical neoplasms with 1597 CINs and 2131
invasive cervical cancers and 6345 controls), which were
published between 1986 and 2008. We present a flow dia-
gram of identification for the relevant studies in Figure 1.
A total of 274 articles were obtained from the three data-
bases and the bibliographies. After excluding the duplicates
(n = 34), all the remaining articles were reviewed (n = 240)
and 193 articles were excluded for not meeting the selec-
tion criteria. After we reviewed the full text for the remain-
ing 47 articles, we included 22 articles in the final analysis.
During the final selection process, the main reasons for
Identified studies from the databases using the keywords and the bibliographies of relevant articles (n = 274):
PubMed (n = 222), EMBASE (n = 34), Cochrane Library (n = 18)
Excluded with duplicates (n = 34)  
Articles after excluded duplicates (n = 240) 
Excluded according to selection criteria during 1st screening (n = 193) 
Articles reviewed including the full text (n = 47) 
Excluded articles (n = 25):   
Insufficient data (n = 11)
Not relevant (n = 8)
Case-control studies included in the final analysis (n = 22): 
H it l b d t l t di ( 15) l ti b d t l t di ( 4) d t d
Shared an identical population (n = 4)
Inclusion of cases not confirmed by biopsy (n = 2)
osp a - ase  case-con ro  s u es n = , popu a on- ase  case-con ro  s u es n = , an  nes e
case-control studies (n = 3)
Figure 1. Flow diagram of identification of relevant studies.
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exclusion were as follows (n = 25): insufficient data
(n = 11), not relevant (n = 8), sharing identical partici-
pants (n = 9), and inclusion of disease not confirmed by
biopsy (n = 2).
Table S1 shows the main characteristics of all 22 studies
included in the final analysis. The countries in which the
studies were conducted were as follows: USA (n = 12), UK
(n = 2), Japan (n = 2), Poland (n = 2), four Latin Ameri-
can countries (n = 2), Finland and Sweden (n = 1), and
Thailand (n = 1). Overall, the range of enrolment periods
for participants was 1975–1998. In studies in which the age
was reported, the mean age was 42.2 years (range 18–
90 years).
Preventive effects of vitamin or antioxidant intake
(or serum level) on cervical neoplasm by type of
vitamin or antioxidant
As shown in Figure 2, meta-analyses by type of vitamin or
antioxidant showed significant preventive effects on cervical
neoplasm (cervical dysplasia, CIS and invasive cancer) in
the highest intake (or serum level) group of vitamin B12
(OR 0.35, 95% CI 0.19–0.63, I2 = 0.0%, n = 2), vitamin C
(OR 0.67, 95% CI 0.55–0.82, I2 = 13.6%, n = 8), vitamin E
(OR 0.56, 95% CI 0.35–0.88, I2 = 66.1%, n = 10), beta-car-
otene (OR 0.68, 95% CI 0.55–0.84, I2 = 32.1%, n = 9),
folate (OR 0.60, 95% CI 0.41–0.88, I2 = 59.8%, n = 9) and
lycopene (OR 0.54, 95% CI 0.39–0.75, I2 = 4.4%, n = 5),
compared with the lowest intake (or serum level) group.
However, these preventive effects were not found for vita-
min A (OR 1.05, 95% CI 0.76–1.46, I2 = 52.0%, n = 12)
and selenium (OR 0.82, 95% CI 0.57–1.18, I2 = 0.0%,
n = 3).
Preventive effects of vitamin or antioxidant intake
(or serum level) on cervical neoplasm by type of
neoplasm
Table 1 shows preventive effects of vitamin or antioxidant
intake (or serum level) on cervical neoplasm by type of
neoplasm such as CIN and invasive cancer. The highest
intake (or serum level) of vitamin B12, vitamin C, vitamin
E and lycopene was significantly associated with a
decreased risk of CIN compared with the lowest intake (or
serum level), whereas no association was observed for vita-
min A, beta-carotene, folate and selenium.
Also, the intake (or serum level) of vitamin C, folate and
lycopene was associated with a decreased risk of invasive
cancer, whereas no preventive effect was found in vitamin
A, vitamin E, beta-carotene and selenium.
Subgroup meta-analysis by adjustment for
HPV infection
As shown in Table 2, when using data from the studies
with adjustment for HPV infection, preventive effects on
cervical neoplasm were found in intakes of vitamin B12,
vitamin C, vitamin E and lycopene, but no preventive effect
was found in vitamin A, beta-carotene, folate and sele-
nium.
Discussion
In the current meta-analysis of case–control studies, we
found that the preventive effect on cervical neoplasm was
found in the high intake (or serum level) of vitamins or
antioxidants such as vitamin B12, vitamin C, vitamin E,
beta-carotene, folate and lycopene, whereas no preventive
effect was observed for vitamin A and selenium. In sub-
group meta-analyses by type of cervical neoplasm, the high-
est intake (or serum level) of vitamin C and lycopene
decreased a risk for both CIN and invasive cervical cancer.
Furthermore, when using data from the studies with
adjustment for HPV infection, preventive effects on cervical
neoplasm were found for intakes of vitamin B12, vitamin C,
vitamin E and lycopene.
Our findings support the possible protective role of vari-
ous vitamins and antioxidants on cervical cancer suggested
in previous literature. Folate is generally known to be
required for DNA synthesis, repair and methylation, and
low folate status might facilitate the incorporation of HPV
into the host genome.24,32,33 Vitamin B12 is associated with
cellular folate uptake.10,23 Also, vitamin B12 and folate are
both cofactors for methionine synthase, which catalyses the
conversion of homocysteine, and are inversely associated
with homocysteine levels.23,34,35 Homocysteine could be
associated with increased risk of cervical cancer as a marker
of low folate and vitamin B12 levels.23,34 However, more
research is required to confirm the protective role of vita-
min B12 because only two case–control studies were
included in our study through a paucity of individual
studies.
Vitamin C, vitamin E, beta-carotene and lycopene,
known as potent antioxidants that can prevent reactive
oxygen species from oxidising cellular proteins and DNA,
are considered to have anti-neoplastic effects in the cer-
vix.20,36 Selenium has also been known to have antioxidant
properties and chemopreventive effects on cancer in animal
studies in vivo and in laboratory studies in vitro.37–39 How-
ever, the role of selenium in cervical neoplasm develop-
ment remains unclear, and only a few case–control studies
have been published on this issue. We are therefore unable
to draw a definite conclusion regarding the effect of sele-
nium on cervical neoplasm, and further research is
required.
Retinol, the animal form of vitamin A, and its metabo-
lites (retinoids) play an important role in cell proliferation
and differentiation, and have also been known to modulate
immune responses.40 In our study, however, unlike other
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vitamins or antioxidants, there was no significant associa-
tion between intake or serum level of vitamin A and cervi-
cal neoplasm, although a few studies, up to 12 articles,
have been published and were included in our analysis.
Our study has several limitations. First, it does not pro-
vide a high level of evidence because we only included
case–control studies because of the paucity of data from
prospective cohort studies or RCTs. Generally, case–control
studies have two main biases, recall and selection. As for
recall bias, women with cervical cancer might recall their
dietary habits towards an unhealthy diet, differently from
healthy people, who may report a healthy diet.41,42 In
addition, it is known that the accuracy of recalling past die-
tary habits is influenced by current dietary habits.43 Both
cases and controls could not represent the whole popula-
tion because they were a non-random sample of a popula-
tion, which causes some members of the population to be
more likely to be included than others. For example, the
association between green tea consumption and risk of
stomach cancer might be an example of the distinct dis-
crepancy in findings between case–control studies and
cohort studies. Myung et al.44 reported that unlike the
case–control studies (relative risk [RR] 0.73; 95% CI 0.64–
0.83; n = 8), no preventive effect on stomach cancer was
A  Vitamin A (n = 12)† B  Vitamin B12 (n = 2)*
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Figure 2. Association between vitamin and an antioxidant intake and cervical neoplasm (dysplasia, carcinoma in situ, and invasive cancer) risk by
type of vitamin or antioxidant. *Fixed effects model; random effects model; OR, odds ratio; 95% CI, 95% confidence interval.
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Vitamin A 7 0.88 (0.34–2.27) 82.8 Random-effects
Vitamin B12 1 0.30 (0.20–0.80) n.a. n.a.
Vitamin C 5 0.67 (0.46–0.98) 43.6 Fixed-effects
Vitamin E 6 0.40 (0.19–0.85) 65.2 Random-effects
Beta-carotene 5 0.64 (0.39–1.04) 0.0 Fixed-effects
Folate 5 0.47 (0.21–1.09) 71.8 Random-effects
Lycopene 3 0.38 (0.19–0.74) 0.0 Fixed-effects
Selenium 1 0.61 (0.20–1.85) n.a. n.a.
Invasive cancer
Vitamin A 5 0.74 (0.40–1.35) 74.5 Random-Effects
Vitamin C 3 0.67 (0.52–0.86) 20.1 Fixed-Effects
Vitamin E 3 0.87 (0.35–2.14) 70.6 Random-Effects
Beta-carotene 4 0.68 (0.44–1.05) 51.5 Random-Effects
Folate 4 0.75 (0.57–0.98) 33.7 Fixed-Effects
Lycopene 1 0.65 (0.44–0.98) n.a. n.a.
Selenium 1 0.99 (0.54–1.81) n.a. n.a.
n.a., not available.











Unadjusted 8 0.96 (0.58–1.58) 60.5 Random-effects
Adjusted 4 1.18 (0.90–1.54) 0.0 Fixed-effects
Vitamin B12 (All studies adjusted)
Unadjusted n.a.
Adjusted 2 0.35 (0.19–0.63) 0.0 Fixed-effects
Vitamin C
Unadjusted 4 0.68 (0.51–0.92) 48.4 Fixed-effects
Adjusted 4 0.66 (0.51–0.86) 0.0 Fixed-effects
Vitamin E
Unadjusted 7 0.58 (0.31–1.07) 75.7 Random-effects
Adjusted 3 0.49 (0.28–0.86) 0.0 Fixed-effects
Beta-carotene
Unadjusted 6 0.60 (0.46–0.78) 44.5 Fixed-effects
Adjusted 3 0.83 (0.60–1.17) 0.0 Fixed-effects
Folate
Unadjusted 4 0.45 (0.25–0.80) 59.8 Random-effects
Adjusted 5 0.86 (0.64–1.16) 45.7 Fixed-effects
Lycopene
Unadjusted 3 0.57 (0.40–0.81) 34.3 Fixed-effects
Adjusted 2 0.45 (0.21–0.98) 0.0 Fixed-effects
Selenium
Unadjusted 2 0.73 (0.46–1.16) 0.0 Fixed-effects
Adjusted 1 0.99 (0.54–1.81) n.a. n.a.
n.a., not available.
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seen for the highest green tea consumption in the meta-
analysis of the recent cohort studies (RR 1.04; 95% CI
0.93–1.17; n = 7). Therefore, further research providing a
higher level of evidence such as prospective cohort studies
or RCTs is needed to confirm the protective effect of vita-
min or antioxidant intake on cervical neoplasm.
Second, many of the individual studies included in
our analysis did not consider HPV infection in their
individual analyses. However, when subgroup meta-analy-
ses by adjustment for HPV infection were performed,
similar findings were observed in subgroup meta-analyses
of both studies with and without adjustment for HPV
infection.
Last, we were unable to evaluate the dose–response
relationship between vitamin or antioxidant intake and
the risk of cervical neoplasm because we used only the
extreme categories, highest versus lowest intake (or serum
level). Also, we could not provide appropriate intake lev-
els of vitamins or antioxidants for the prevention of cer-
vical neoplasm. Those should be evaluated in the future
research.
In conclusion, we found that there were significant pro-
tective effects of some vitamin or antioxidant intake on
cervical neoplasm in the meta-analysis of case–control
studies. However, given that case–control studies have
potential biases, our findings and explanations should be
confirmed in further research, such as prospective cohort
studies and RCTs providing the highest level of evidence.
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